Asaoku Hideki | Clinical Laboratory Hiroshima Red Cross Hospital Atomic-bomb Survivors Hospital

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
CD56 expression in human myeloma cells derived from the neurogenic gene expression : possible role of the SRY-HMG box gene, SOX4
Use of Octreotide in the Management of Severe Duodenal Bleeding after Unrelated-Donor Bone Marrow Transplantation
Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Multiple Myeloma : Results from the Japan Myeloma Study Group
Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
Mikulicz's disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient
Acquired Storage-Pool Disorders Occurring Late After Allogeneic Bone Marrow Transplantation: Partial Activation of Platelets in Asymptomatic Patients
Utility and Safety of Hickman Catheters for Venous Access after Bone Marrow Transplantation
Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
Endoscopic Findings of Acute Intestinal Graft-versus-host Disease after Bone Marrow Transplantation
Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion
Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation
Frequent Exacerbation of Pulmonary Nocardiosis during Maintenance Antibiotic Therapies in a Hematopoietic Stem Cell Transplant Recipient
Immune-Mediated Myelopathy following Allogeneic Stem Cell Transplantation
Pneumatosis coli after Thalidomide Treatment
Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation
Cytogenetic Abnormalities without Evidence of Relapse after Treatment with Imatinib and Stem Cell Transplantation in a Patient with Ph-Positive ALL
Bone marrow transplantation in subjects with mental disorders
IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33(+) myeloma cells
An Increase in MPC-1^- and MPC-1^-CD45^+ Immature Myeloma Cells in the Progressive States of Bone Marrow Plasmacytosis : The Revised Phenotypic Classification of Monoclonal Marrow Plasmacytosis (MOMP-2005)
Variation of Oceanic Condition in Hyuga-Nada, Japan
Psychological factors and survival after bone marrow transplantation in patients with leukemia
Hepatitis B Virus Reactivation in a Patient With Chronic GVHD After Allogeneic Peripheral Blood Stem Cell Transplantation
Recombinant human erythropoetin (rhEPO) administration to marrow donors
Imatinib Mesylate (Gleevec) in the Treatment of 2 Patients with Philadelphia-Positive ALL Relapsing after Allogeneic Stem Cell Transplantation
Successful Unrelated Bone Marrow Transplantation After Arsenic Trioxide Treatment in a Patient With Relapsed Acute Promyelocytic Leukemia
Erythrocytosis caused by erythropoietin-producing thymic carcinoma
Low-Dose Antithymocyte Globulin for Treatment of Steroid-Pulse-Resistant Acute Graft-versus-Host Disease
Effect of Additional Chromosomal Abnormalities in Acute Promyelocytic Leukemia Treated With All-trans-Retinoic Acid: A Report of 17 Patients
Second Allogeneic Peripheral Blood Stem Cell Transplantation With Fludarabine-Based Low-Intensity Conditioning Regimen for Relapsed Myelodysplastic Syndrome After Allogeneic Bone Marrow Transplantation
Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes

もっと見る

スポンサーリンク